Lobão R, Carvalho A B, Cuppari L, Ventura R, Lazaretti-Castro M, Jorgetti V, Vieira J G, Cendoroglo M, Draibe S A
Federal University of São Paulo, Escola Paulista de Medicina, São Paulo, Brazil.
Clin Nephrol. 2004 Dec;62(6):432-9. doi: 10.5414/cnp62432.
Chronic kidney disease (CKD) leads to reduced bone mineral density (BMD) in pre-dialysis and dialysis patients. A few studies have used dual-energy x-ray absorptiometry (DEXA) to assess BMD in pre-dialysis CKD patients and have shown low BMD to be highly prevalent. Until now there have been no studies reporting the histological features of low BMD in pre-dialysis CKD patients.
To determine the prevalence and histological features of low BMD in pre-dialysis CKD patients.
Pre-dialysis CKD patients (n = 103, 46 females/57 males), median creatinine clearance of 29 (10 - 78) ml/min/ 1.73 m2, were evaluated using biochemical analysis and DEXA. Bone biopsies were obtained from those with low BMD.
Fifty (48.5%) out of the 103 patients had low BMD (LBD group) and 53 (51.5%) had normal BMD (NBD group). The risk for low BMD was increased in those patients with alkaline phosphatase levels above 190 U/l and intact-PTH (iPTH) below 70 pg/ml (p < 0.05). Demographic and biochemical parameters from both groups were comparable, except for lower body mass index (BMI) in LBD subjects (p = 0.04). Women who had been post-menopausal for at least 1 year comprised 65% (13/20) and 50% (13/26) of the LBD and NBD groups, respectively (p = NS). In 40 LBD patients, bone histomorphometry revealed adynamic bone disease (ABD, 52.5%), osteomalacia (OM, 42.5%) and mixed bone disease (MBD, 5%). Trabecular bone volume (BV/TV) was lower in ABD and OM patients. A nearly significant association was found between ABD and iPTH < or = 150 pg/ml (p = 0.056), whereas higher values of iPTH were associated with OM. Total alkaline phosphatase < or = 190 U/l was significantly associated with ABD, whereas higher values were associated with OM. No correlation was observed between BV/TV and BMD.
Low BMD is frequent in pre-dialysis CKD patients, and low turnover bone disease, manifesting as ABD and OM, was the hallmark of this bone loss.
慢性肾脏病(CKD)会导致透析前及透析患者的骨矿物质密度(BMD)降低。一些研究使用双能X线吸收法(DEXA)评估透析前CKD患者的BMD,结果显示低BMD非常普遍。到目前为止,尚无研究报道透析前CKD患者低BMD的组织学特征。
确定透析前CKD患者低BMD的患病率及组织学特征。
对透析前CKD患者(n = 103,女性46例/男性57例)进行评估,其肌酐清除率中位数为29(10 - 78)ml/min/1.73 m²,采用生化分析和DEXA。对低BMD患者进行骨活检。
103例患者中有50例(48.5%)BMD低(低BMD组),53例(51.5%)BMD正常(正常BMD组)。碱性磷酸酶水平高于190 U/l且全段甲状旁腺激素(iPTH)低于70 pg/ml的患者发生低BMD的风险增加(p < 0.05)。两组的人口统计学和生化参数具有可比性,但低BMD组的体重指数(BMI)较低(p = 0.04)。绝经至少1年的女性在低BMD组和正常BMD组中分别占65%(13/20)和50%(13/26)(p = 无显著性差异)。在40例低BMD患者中,骨组织形态计量学显示骨转化减低型骨病(ABD,52.5%)、骨软化症(OM,42.5%)和混合性骨病(MBD,5%)。ABD和OM患者的骨小梁体积(BV/TV)较低。ABD与iPTH≤150 pg/ml之间存在近乎显著的关联(p = 0.056),而较高水平的iPTH与OM相关。总碱性磷酸酶≤190 U/l与ABD显著相关,而较高值与OM相关。未观察到BV/TV与BMD之间的相关性。
透析前CKD患者中低BMD很常见,以ABD和OM表现的低转换型骨病是这种骨质流失的标志。